Q4 2022 Earnings Report

Q4&FY 2022 Results Segment Adjusted EBITDA to IFRS Net Loss Q4 2022 (1) Q4 2021 (1) FY 2022 (1) FY 2021 (1) in millions, unless otherwise stated Total Segment Adjusted EBITDA (2,5) (non-IFRS) 112 (113) 65 (125) Regional Corporate Costs (3) Adjusted EBITDA (4,5) (non-IFRS) Non-cash expenses ཀླིĒ (223) (192) (858) (717) (111) (305) (793) (842) (263) (719) (863) (2,541) Cash expenses Loss for the period (17) (76) (84) (172) (391) (1,100) (1,740) (3,555) Note: 1. Unaudited for Q4 2021, Q4 2022, FY 2021 and FY 2022. 2. Total Segment Adjusted EBITDA is a non-IFRS financial measure, representing the sum of Adjusted EBITDA of our four business segments. 3. Regional corporate costs are costs that are not attributed to any of the business segments, including certain regional research and development expenses, general and administrative expenses and marketing expenses. These regional research and development expenses also include mapping and payment technologies and support and development of the internal technology infrastructure. These general and administrative expenses also include certain shared costs such as finance, accounting, tax, human resources, technology and legal costs. Regional corporate costs exclude share-based compensation expenses. 4. Adjusted EBITDA is defined as net loss adjusted to exclude: (i) net interest income (expenses), (ii) other income (expenses), (iii) income tax expenses, (iv) depreciation and amortization, (v) stock-based compensation expenses, (vi) costs related to mergers and acquisitions, (vii) unrealized foreign exchange gain (loss), (viii) impairment losses on goodwill and non-financial assets, (ix) fair value changes on investments, (x) restructuring costs, (xi) legal, tax and regulatory settlement provisions and (xii) share listing and associated expenses. 5. These are non-IFRS financial measures. For a reconciliation to the most directly comparable IFRS measure see the section titled "Non-IFRS Reconciliation." 16

View entire presentation